ARS Pharmaceuticals Says For Eligible Patients Without Insurance Coverage, Co Will Offer A Cash Price Of $199 For Two Doses Of neffy Via BlinkRx
Portfolio Pulse from Benzinga Newsdesk
ARS Pharmaceuticals announced that for eligible patients without insurance coverage, the company will offer a cash price of $199 for two doses of neffy via BlinkRx.
August 09, 2024 | 4:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ARS Pharmaceuticals (SPRY) will offer two doses of neffy for $199 via BlinkRx for eligible patients without insurance coverage.
The announcement of a $199 cash price for two doses of neffy via BlinkRx for eligible patients without insurance coverage is likely to positively impact ARS Pharmaceuticals (SPRY) in the short term. This move could increase accessibility and sales of neffy, potentially boosting revenue.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100